低分子API連続製造の市場規模、シェア、動向分析レポート：装置別、ユニットオペレーション別、タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年

低分子API連続製造市場の成長と動向：

Grand View Research, Inc.の調査レポートによると、低分子API連続製造の世界市場規模は2030年までに6億7,152万米ドルに達し、2024年から2030年までのCAGRは10.42％で成長すると予測されています。

この堅調な拡大は、現在の業界動向、技術の進歩、規制状況の変化を反映したいくつかの主要な促進要因によるものです。連続製造プロセスは、従来のバッチ処理に比べて、効率の向上、製造コストの削減、製品品質の向上など、大きな利点を提供します。米国食品医薬品局（FDA）は、医薬品製造プロセスを合理化し、医薬品全体の品質を向上させる可能性を認識し、連続製造技術を積極的に推進してきました。例えば、FDAの「21世紀の医薬品品質」イニシアティブでは、連続製造が重要な重点分野として取り上げられ、製造変数をより確実に管理するために、これらの革新的なアプローチを採用するよう企業に奨励しています。

最近の技術的進歩が連続製造市場をさらに後押ししています。プロセス分析技術（PAT）の革新は、生産プロセスのリアルタイムモニタリングを可能にし、一貫した品質と規制基準の遵守を保証します。例えば、2024年7月、GEAは医薬品製造の柔軟性と効率性を高めるために設計された新しい連続処理技術を発表しました。ACHEMA 2024において、GEAはホビオネ社とのコラボレーションを展示し、ConsiGma CDCフレックスシステムを強調しました。このシステムは、さまざまなスループットで連続とバッチの両方のプロセスをサポートし、生産品質と持続可能性を向上させます。これらの技術は、効率を高めるだけでなく、新薬の市場投入までの時間を大幅に短縮し、競争が激化する製薬業界に不可欠な要素となっています。

連続製造市場の成長には、政府の取り組みや支援も重要な役割を果たしています。様々な国が、競争力を強化し、公衆衛生の成果を向上させるために、医薬品製造における近代化の必要性を認識しています。例えば米国政府は、連続製造技術の採用を促進することを目的としたプログラムを導入し、業界内のイノベーションを支援するための資金やリソースを提供しています。同様に、欧州医薬品庁（EMA）は、欧州の製薬セクターにおいてこれらの技術の導入を促進するガイドラインを推進し、連続プロセスの使用を奨励しています。

低分子API連続製造市場レポートハイライト

• 装置別では、リアクターが2023年に35.2%の大幅なシェアで市場を席巻し、予測期間中に11.0%のCAGRで最速の成長が見込まれます。
• 装置別では、合成装置が2023年に39.1%と最大の売上シェアを占め、技術的進歩、効率向上、持続可能な実践へのシフトに牽引され、今後数年間は継続的な拡大が見込まれます。
• タイプ別では、ジェネリック原薬が市場を独占し、2023年には10.8%の大幅な収益シェアを獲得しました。
• 最終用途別では、CMO/CDMOが市場を席巻し、2023年には70.2%の大幅な収益シェアを獲得しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 低分子API連続製造市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 低分子API連続製造市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 低分子API連続製造市場：設備の推定・動向分析

• 低分子API連続製造の世界市場：機器ダッシュボード
• 低分子API連続製造の世界市場：設備変動分析
• 低分子API連続製造の世界市場：設備別収益
• 原子炉
• 結晶化装置
• 濾過システム
• ミキサー
• 熱交換器
• その他（乾燥機等）

第5章 低分子API連続製造市場：ユニットオペレーションの推定・動向分析

• 低分子API連続製造の世界市場：ユニット操作ダッシュボード
• 低分子API連続製造の世界市場：ユニット操作変動分析
• ユニットオペレーション別収益
• 合成
• 分離と精製
• 乾燥

第6章 低分子API連続製造市場：タイプ推定・動向分析

• 低分子API連続製造の世界市場：タイプダッシュボード
• 低分子API連続製造の世界市場：タイプ変動分析
• タイプ別収益
• 汎用API
• 革新的なAPI

第7章 低分子API連続製造市場：最終用途の推定・動向分析

• 低分子API連続製造の世界市場：最終用途ダッシュボード
• 低分子API連続製造の世界市場：最終用途変動分析
• 最終用途別収益
• CMO/CDMO
• 製薬会社
• 学術研究機関

第8章 低分子API連続製造市場：機器、ユニットオペレーション、タイプ、最終用途別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • Key company market share analysis, 2023
  • Pfizer Inc
  • GSK plc.（GlaxoSmithKline）
  • Vertex Pharmaceuticals Incorporated
  • Janssen（a subsidiary of Johnson &Johnson）
  • Abbvie Inc.
  • Sterling Pharma Solutions
  • Evonik Industries AG
  • Cambrex Corporation
  • Patheon
  • Hovione
  • Lonza
  • Phlow
  • Asymchem
  • GEA Group AG
  • Thermo Fisher Scientific
  • Corning Incorporated
  • Coperion GmbH
  • Continuus Pharmaceuticals
  • Chemtrix
  • Vapourtec Ltd
  • Ehrfeld Mikrotechnik GmbH
  • NiTech Solutions Ltd

List of Tables

• Table 1 List Of Abbreviation
• Table 2 North America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
• Table 3 North America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 4 North America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 5 North America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 6 North America Continuous Manufacturing for Small Molecule APIs Market, End Use, 2018 - 2030 (USD Million)
• Table 7 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 8 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 9 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 10 U.S. Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 11 Canada Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 12 Canada Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 13 Canada Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 14 Canada Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 15 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 16 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 17 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 18 Mexico Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 19 Europe Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
• Table 20 Europe Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 21 Europe Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 22 Europe Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 23 Europe Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 24 Germany Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 25 Germany Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 26 Germany Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 27 Germany Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 28 UK Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 29 UK Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 30 UK Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 31 UK Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 32 France Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 33 France Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 34 France Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 35 France Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 36 Italy Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 37 Italy Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 38 Italy Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 39 Italy Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 40 Spain Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 41 Spain Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 42 Spain Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 43 Spain Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 44 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 45 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 46 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 47 Denmark Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 48 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 49 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 50 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 51 Sweden Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 52 Norway Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 53 Norway Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 54 Norway Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 55 Norway Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 61 China Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 62 China Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 63 China Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 64 China Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 65 Japan Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 66 Japan Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 67 Japan Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 68 Japan Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 69 India Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 70 India Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 71 India Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 72 India Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 73 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 74 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 75 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 76 South Korea Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 77 Australia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 78 Australia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 79 Australia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 80 Australia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 81 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 82 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 83 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 84 Thailand Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 85 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
• Table 86 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 87 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 88 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 89 Latin America Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 90 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 91 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 92 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 93 Brazil Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 94 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 95 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 96 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 97 Argentina Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 98 MEA Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
• Table 99 MEA Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 100 MEA Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 101 MEA Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 102 MEA Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 103 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 104 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 105 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 106 South Africa Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 111 UAE Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 112 UAE Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 113 UAE Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 114 UAE Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
• Table 115 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
• Table 116 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
• Table 117 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
• Table 118 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Continuous Manufacturing for Small Molecule APIs Market: Market Outlook
• Fig. 14 Colorectal Surgery Competitive Insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Continuous Manufacturing for Small Molecule APIs Market Driver Impact
• Fig. 18 Continuous Manufacturing for Small Molecule APIs Market Restraint Impact
• Fig. 19 Continuous Manufacturing for Small Molecule APIs Market Strategic Initiatives Analysis
• Fig. 20 Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
• Fig. 21 Continuous Manufacturing for Small Molecule APIs Market: Equipment Outlook And Key Takeaways
• Fig. 22 Reactors market estimates and forecast, 2018 - 2030
• Fig. 23 Crystallizers market estimates and forecast, 2018 - 2030
• Fig. 24 Filtration Systems market estimates and forecast, 2018 - 2030
• Fig. 25 Mixers market estimates and forecast, 2018 - 2030
• Fig. 26 Heat Exchangers market estimates and forecast, 2018 - 2030
• Fig. 27 Others (Dryers, etc.) market estimates and forecast, 2018 - 2030
• Fig. 28 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
• Fig. 29 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Outlook And Key Takeaways
• Fig. 30 Synthesis market estimates and forecast, 2018 - 2030
• Fig. 31 Separation & Purification Separation & Purification market estimates and forecast, 2018 - 2030
• Fig. 32 Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
• Fig. 33 Continuous Manufacturing for Small Molecule APIs Market: Type Outlook And Key Takeaways
• Fig. 34 Generic APIs market estimates and forecast, 2018 - 2030
• Fig. 35 Innovative APIs market estimates and forecast, 2018 - 2030
• Fig. 36 Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
• Fig. 37 Continuous Manufacturing for Small Molecule APIs Market: End Use Outlook And Key Takeaways
• Fig. 38 CMOs/CDMOs market estimates and forecast, 2018 - 2030
• Fig. 39 Pharmaceutical Companies market estimates and forecast, 2018 - 2030
• Fig. 40 Academic & Research Institutes market estimates and forecast, 2018 - 2030
• Fig. 41 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Movement Analysis
• Fig. 42 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Outlook And Key Takeaways
• Fig. 43 Global Continuous Manufacturing for Small Molecule APIs Market share and leading players
• Fig. 44 North America, by country
• Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 U.S. key country dynamics
• Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Canada key country dynamics
• Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Mexico key country dynamics
• Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 UK key country dynamics
• Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Germany key country dynamics
• Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 France key country dynamics
• Fig. 58 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Italy key country dynamics
• Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Spain key country dynamics
• Fig. 62 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Denmark key country dynamics
• Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Sweden key country dynamics
• Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Norway key country dynamics
• Fig. 68 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 China key country dynamics
• Fig. 71 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Japan key country dynamics
• Fig. 73 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 India key country dynamics
• Fig. 75 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Thailand key country dynamics
• Fig. 77 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 South Korea key country dynamics
• Fig. 79 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Australia key country dynamics
• Fig. 81 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Brazil key country dynamics
• Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Argentina key country dynamics
• Fig. 86 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 South Africa key country dynamics
• Fig. 89 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Saudi Arabia key country dynamics
• Fig. 91 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 UAE key country dynamics
• Fig. 93 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Kuwait key country dynamics
• Fig. 95 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Market share of key market players- Continuous Manufacturing for Small Molecule APIs Market

Continuous Manufacturing For Small Molecule APIs Market Growth & Trends:

The global continuous manufacturing for small molecule APIs market size is anticipated to reach USD 671.52 million by 2030, growing at a CAGR of 10.42% from 2024 to 2030, according to a report by Grand View Research, Inc. This robust expansion can be attributed to several key drivers that reflect current industry trends, advancements in technology, and changing regulatory landscapes. Continuous manufacturing processes offer significant advantages over traditional batch processing, including increased efficiency, reduced production costs, and improved product quality. The United States Food and Drug Administration (FDA) has actively promoted continuous manufacturing technologies, recognizing their potential to streamline the drug production process and enhance the overall quality of pharmaceutical products. For instance, the FDA's "Pharmaceutical Quality for the 21st Century" initiative highlights continuous manufacturing as a key focus area, encouraging companies to adopt these innovative approaches to ensure better control over production variables.

Recent technological advancements further propel the continuous manufacturing market. Innovations in process analytical technology (PAT) enable real-time monitoring of production processes, ensuring consistent quality and compliance with regulatory standards. For instance, in July 2024, GEA introduced new continuous processing technologies designed to enhance flexibility and efficiency in pharmaceutical manufacturing. At ACHEMA 2024, GEA showcased its collaboration with Hovione, emphasizing the ConsiGma CDC flex system. This system supports both continuous and batch processes with varied throughput, improving production quality and sustainability. Their partnership aims to simplify operations and make continuous manufacturing more accessible across the industry.These technologies not only increase efficiency but also significantly shorten time-to-market for new drugs, an essential factor in an increasingly competitive pharmaceutical industry.

Government initiatives and support also play a crucial role in the growth of the continuous manufacturing market. Various countries are recognizing the need for modernization in pharmaceutical manufacturing to enhance competitiveness and improve public health outcomes. For example, the U.S. government has introduced programs aimed at facilitating the adoption of continuous manufacturing technologies, providing funding and resources to support innovation within the industry. Similarly, the European Medicines Agency (EMA) has been encouraging the use of continuous processes, promoting guidelines that facilitate the implementation of these technologies within Europe's pharmaceutical sector.

Continuous Manufacturing For Small Molecule APIs Market Report Highlights:

• Based on equipment, reactors dominated the market with a substantial share of 35.2% in 2023 and are expected to grow at the fastest CAGR of 11.0% during the forecast period
• Based on unit operation, the synthesis segment held the largest revenue share of 39.1% in 2023 driven by technological advancements, efficiency gains, and a shift toward sustainable practices, positioning it for continued expansion in the coming years
• Based on type, generic APIs dominated the market, capturing a substantial revenue share of 10.8% in 2023
• Based on end use, CMO/CDMOs dominated the market, capturing a substantial revenue share of 70.2% in 2023

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Equipment
  • 1.2.2. Unit Operation
  • 1.2.3. Type
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Equipment Outlook
  • 2.2.2. Unit Operation
  • 2.2.3. Type
  • 2.2.4. End Use
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Continuous Manufacturing for Small Molecule APIs Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rapid growth in the global pharmaceutical industry
    • 3.2.1.2. Growing role of flow chemistry in API manufacturing
    • 3.2.1.3. Growing adoption and improved efficiency & productivity
    • 3.2.1.4. Emergence as a green, sustainable and profitable process technology
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High R&D investment and capital cost
    • 3.2.2.2. Regulatory compliance and process validation
• 3.3. Continuous Manufacturing for Small Molecule APIs Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Continuous Manufacturing for Small Molecule APIs Market: Equipment Estimates & Trend Analysis

• 4.1. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Dashboard
• 4.2. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
• 4.3. Global Continuous Manufacturing for Small Molecule APIs Market by Equipment, Revenue
• 4.4. Reactors
  • 4.4.1. Reactors market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Crystallizers
  • 4.5.1. Crystallizers market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Filtration Systems
  • 4.6.1. Filtration Systems market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Mixers
  • 4.7.1. Mixers market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Heat Exchangers
  • 4.8.1. Heat Exchangers market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Others (Dryers, etc.)
  • 4.9.1. Others (Dryers, etc.) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Estimates & Trend Analysis

• 5.1. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Dashboard
• 5.2. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
• 5.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Unit Operation, Revenue (USD Million)
• 5.4. Synthesis
  • 5.4.1. Synthesis market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Separation & Purification
  • 5.5.1. Separation & Purification market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Drying
  • 5.6.1. Drying market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Continuous Manufacturing for Small Molecule APIs Market: Type Estimates & Trend Analysis

• 6.1. Global Continuous Manufacturing for Small Molecule APIs Market: Type Dashboard
• 6.2. Global Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
• 6.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Type, Revenue (USD Million)
• 6.4. Generic APIs
  • 6.4.1. Generic APIs market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Innovative APIs
  • 6.5.1. Innovative APIs market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Continuous Manufacturing for Small Molecule APIs Market: End Use Estimates & Trend Analysis

• 7.1. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Dashboard
• 7.2. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
• 7.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By End Use, Revenue (USD Million)
• 7.4. CMOs/CDMOs
  • 7.4.1. CMOs/CDMOs market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Pharmaceutical Companies
  • 7.5.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Continuous Manufacturing for Small Molecule APIs Market: Regional Estimates & Trend Analysis by Equipment, Unit Operation, Type and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Vendor Landscape
  • 9.2.1. List of key distributors and channel partners
  • 9.2.2. Key company market share analysis, 2023
  • 9.2.3. Pfizer Inc
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Equipment benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. GSK plc. (GlaxoSmithKline)
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Equipment benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Vertex Pharmaceuticals Incorporated
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Equipment benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Janssen (a subsidiary of Johnson & Johnson)
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Equipment benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Abbvie Inc.
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Equipment benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Sterling Pharma Solutions
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Equipment benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Evonik Industries AG
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Equipment benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Cambrex Corporation
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Equipment benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Patheon
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Equipment benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12. Hovione
    • 9.2.12.1. Company overview
    • 9.2.12.2. Financial performance
    • 9.2.12.3. Equipment benchmarking
    • 9.2.12.4. Strategic initiatives
  • 9.2.13. Lonza
    • 9.2.13.1. Company overview
    • 9.2.13.2. Financial performance
    • 9.2.13.3. Equipment benchmarking
    • 9.2.13.4. Strategic initiatives
  • 9.2.14. Phlow
    • 9.2.14.1. Company overview
    • 9.2.14.2. Financial performance
    • 9.2.14.3. Equipment benchmarking
    • 9.2.14.4. Strategic initiatives
  • 9.2.15. Asymchem
    • 9.2.15.1. Company overview
    • 9.2.15.2. Financial performance
    • 9.2.15.3. Equipment benchmarking
    • 9.2.15.4. Strategic initiatives
  • 9.2.16. GEA Group AG
    • 9.2.16.1. Company overview
    • 9.2.16.2. Financial performance
    • 9.2.16.3. Equipment benchmarking
    • 9.2.16.4. Strategic initiatives
  • 9.2.17. Thermo Fisher Scientific
    • 9.2.17.1. Company overview
    • 9.2.17.2. Financial performance
    • 9.2.17.3. Equipment benchmarking
    • 9.2.17.4. Strategic initiatives
  • 9.2.18. Corning Incorporated
    • 9.2.18.1. Company overview
    • 9.2.18.2. Financial performance
    • 9.2.18.3. Equipment benchmarking
    • 9.2.18.4. Strategic initiatives
  • 9.2.19. Coperion GmbH
    • 9.2.19.1. Company overview
    • 9.2.19.2. Financial performance
    • 9.2.19.3. Equipment benchmarking
    • 9.2.19.4. Strategic initiatives
  • 9.2.20. Continuus Pharmaceuticals
    • 9.2.20.1. Company overview
    • 9.2.20.2. Financial performance
    • 9.2.20.3. Equipment benchmarking
    • 9.2.20.4. Strategic initiatives
  • 9.2.21. Chemtrix
    • 9.2.21.1. Company overview
    • 9.2.21.2. Financial performance
    • 9.2.21.3. Equipment benchmarking
    • 9.2.21.4. Strategic initiatives
  • 9.2.22. Vapourtec Ltd
    • 9.2.22.1. Company overview
    • 9.2.22.2. Financial performance
    • 9.2.22.3. Equipment benchmarking
    • 9.2.22.4. Strategic initiatives
  • 9.2.23. Ehrfeld Mikrotechnik GmbH
    • 9.2.23.1. Company overview
    • 9.2.23.2. Financial performance
    • 9.2.23.3. Equipment benchmarking
    • 9.2.23.4. Strategic initiatives
  • 9.2.24. NiTech Solutions Ltd
    • 9.2.24.1. Company overview
    • 9.2.24.2. Financial performance
    • 9.2.24.3. Equipment benchmarking
    • 9.2.24.4. Strategic initiatives